Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
collagen type IV alpha 6 chain | 0.686 | 0.423 | 0.90 |
|
group | 0.020 | None | 1.000 | 1 | 0 | 2004 | 2013 | ||||||||
|
catenin beta interacting protein 1 | 0.663 | 0.423 | 2.5E-02 |
|
group | 0.020 | None | 1.000 | 1 | 0 | 2002 | 2008 | ||||||||
|
prostaglandin F receptor | 0.705 | 0.423 | 6.6E-02 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
somatostatin receptor 3 | 0.659 | 0.423 | 9.9E-05 |
|
group | 0.020 | None | 1.000 | 1 | 0 | 2004 | 2007 | ||||||||
|
protein tyrosine phosphatase 4A2 | 0.695 | 0.423 | 0.97 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
FRAT regulator of WNT signaling pathway 1 | 0.653 | 0.462 | 0.32 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
RAB32, member RAS oncogene family | 0.711 | 0.462 | 6.5E-04 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
nudix hydrolase 6 | 0.705 | 0.462 | 2.9E-05 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
cytochrome P450 family 2 subfamily A member 13 | 0.695 | 0.462 | 8.6E-07 |
|
group | 0.020 | None | 1.000 | 1 | 0 | 2003 | 2013 | ||||||||
|
stomatin like 2 | 0.601 | 0.462 | 2.4E-03 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
SH3 domain containing GRB2 like, endophilin B1 | 0.716 | 0.462 | 0.99 |
|
group | 0.020 | None | 1.000 | 1 | 0 | 2006 | 2008 | ||||||||
|
tripartite motif containing 25 | 0.633 | 0.462 | 4.1E-03 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
CDK5 regulatory subunit associated protein 3 | 0.700 | 0.462 | 7.6E-15 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
cellular communication network factor 5 | 0.621 | 0.462 | 2.0E-05 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
dual specificity tyrosine phosphorylation regulated kinase 1B | 0.647 | 0.462 | 0.97 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
estrogen receptor binding site associated antigen 9 | 0.615 | 0.462 | 7.7E-02 |
|
group | 0.040 | None | 1.000 | 1 | 0 | 2001 | 2015 | ||||||||
|
transmembrane protein with EGF like and two follistatin like domains 2 | 0.619 | 0.500 | 7.4E-05 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2002 | 2006 | ||||||||
|
transmembrane serine protease 2 | 0.615 | 0.500 | 2.4E-10 |
|
group | 0.060 | None | 1.000 | 2 | 0 | 2001 | 2011 | ||||||||
|
cyclin B2 | 0.686 | 0.500 | 5.7E-12 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2007 | 2007 | ||||||||
|
atonal bHLH transcription factor 1 | 0.633 | 0.500 | 1.8E-02 |
|
group | 0.020 | None | 1.000 | 1 | 0 | 2004 | 2007 | ||||||||
|
MAGE family member C2 | 0.656 | 0.500 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2004 | 2004 | |||||||||
|
CUB and Sushi multiple domains 1 | 0.610 | 0.500 | 1.00 |
|
group | 0.020 | None | 1.000 | 1 | 0 | 2004 | 2008 | ||||||||
|
protein phosphatase 1 regulatory inhibitor subunit 1B | 0.617 | 0.500 | 0.24 |
|
group | 0.020 | None | 1.000 | 1 | 0 | 2003 | 2016 | ||||||||
|
solute carrier family 28 member 1 | 0.686 | 0.538 | 5.7E-20 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2003 | 2004 | ||||||||
|
alpha-1-B glycoprotein | 0.700 | 0.538 | 5.0E-09 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 |